Product Information Gefitinib Tablets 250 mg are prescription targeted anticancer medicines belonging to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) class. They are prescribed for selected patients with EGFR mutation-positive non-small cell lung cancer (NSCLC). By specifically targeting abnormal EGFR activity, Gefitinib helps reduce cancer cell growth while allowing a more targeted treatment approach. What Special Precautions Should I Follow? Important precautions include: Inform your doctor about any history of lung disease, liver disorders, or eye problems. Routine liver function tests and clinical monitoring may be recommended during treatment. Tell your healthcare provider about all prescription medicines, herbal supplements, and over-the-counter products you are taking, as some medicines may interact with Gefitinib. Women who are pregnant or planning pregnancy should avoid this medicine unless specifically advised by their physician. What Special Dietary Instructions Should I Follow? Maintain good hydration unless otherwise instructed. Follow a balanced, nutritious diet to support overall health during treatment. Discuss any dietary supplements with your healthcare provider before use. Avoid making significant dietary changes without consulting your treating physician. What Other Information Should I Know? Keep out of the reach of children. Do not share prescription medicines with others. Attend all scheduled medical appointments and laboratory monitoring. Dispose of unused or expired medicines according to local pharmaceutical disposal regulations. Always verify batch details and expiry dates before use. Why Choose Gefitinib from India? ✔ GMP compliant manufacturing facilities ✔ Reliable international pharmaceutical exporter ✔ Bulk quantities for commercial procurement ✔ Secure export packaging ✔ Competitive global supply chain Frequently Asked Questions 1. What is Gefitinib Tablets 250 mg used for? Gefitinib is prescribed for selected patients with EGFR mutation-positive non-small cell lung cancer under the supervision of an oncology specialist. 2. Can Gefitinib be purchased in bulk for hospitals? Yes. Licensed hospitals, pharmaceutical distributors, government procurement agencies, and authorized importers may purchase commercial quantities according to local regulations. 3. Is a prescription required? Yes. Gefitinib Tablets are prescription-only medicines and should be used only under medical supervision. 4. What documents are available for export orders? Export orders are supported with essential shipping and quality documents, subject to the destination country's import regulations. 5. Why do global buyers choose Indian pharmaceutical suppliers? Indian pharmaceutical exporters are recognized for international manufacturing standards, competitive pricing, reliable production capacity, and efficient global distribution networks. Gefitinib Tablets 250 mg Supplier from India Buy Gefitinib Tablets Online Gefitinib Exporter India Lung Cancer Medicine Export Oncology Tablet Distributor Bulk Gefitinib Tablets Targeted Cancer Medicine Supplier Gefitinib Wholesale Distributor 🏥 Your Trusted Global Partner for Oncology Pharmaceuticals [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Bulk Supply 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 #Gefitinib250mg #GefitinibTablets #TargetedTherapy #LungCancerMedicine #EGFRInhibitor #OncologyMedicine #MedicineSupplierIndia #PharmaceuticalExporter #CancerCare #HospitalProcurement #GlobalHealthcare #BulkPharma #HealthcareDistribution #IndianPharma #OncologyDistributor #MedicalExports #PrecisionMedicine #WorldwidePharma #CancerTreatment #ErnestPharmaceutical

Geftib 250mg (Gefitinib) Tablet Geftib 250mg Tablet contains Gefitinib, a targeted therapy medicine used in the treatment of non-small cell lung cancer (NSCLC). Gefitinib belongs to the class of medicines known as tyrosine kinase inhibitors, which work by blocking signals that stimulate the growth and spread of cancer cells. Gefitinib tablets are commonly prescribed for patients with EGFR mutation-positive lung cancer and should be taken under the supervision of a qualified healthcare professional. Ernest Oncology supplies Geftib 250mg (Gefitinib) Tablets globally with secure packaging, competitive export pricing, and reliable international delivery. Product Information (Text Format) Product Name: Geftib Tablet Generic Name: Gefitinib Strength: 250mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor Packaging Type: Tablet Strip / Box Route of Administration: Oral Manufacturer: Pharmaceutical Exporter: Ernest Oncology / Ernest Pharmaceutical Pvt. Ltd. Country of Origin: India Uses of Geftib 250mg Tablet Geftib (Gefitinib) Tablet is used in the treatment of: • Non-Small Cell Lung Cancer (NSCLC) • EGFR Mutation Positive Lung Cancer • Advanced or Metastatic Lung Cancer It helps slow the growth of cancer cells and may reduce the spread of tumors. How Geftib Tablet Works Gefitinib works by blocking the epidermal growth factor receptor (EGFR) on cancer cells. By inhibiting this receptor, the medicine prevents signals that promote cancer cell growth and division. Administration Geftib 250mg Tablet should be taken: • As prescribed by a qualified healthcare professional • Usually once daily • Swallowed whole with water • With or without food Dosage and treatment duration depend on the patient’s medical condition and response to therapy. Possible Side Effects Some patients may experience: • Diarrhea • Skin rash • Nausea • Loss of appetite • Fatigue • Dry skin Patients should consult their healthcare provider if side effects persist or worsen. Storage Instructions • Store below 25°C • Keep in a cool and dry place • Protect from moisture and sunlight • Keep out of reach of children Why Choose Ernest Oncology? Ernest Oncology, a group of Ernest Pharmaceutical Pvt. Ltd., is a trusted global pharmaceutical exporter from India supplying oncology medicines worldwide. ✔ GMP quality medicines ✔ Global pharmaceutical exporter ✔ Bulk supply for hospitals and distributors ✔ Competitive international pricing ✔ Secure export packaging ✔ Worldwide shipping and export documentation support We export medicines to: USA • UK • UAE • Australia • Singapore • South Africa • Europe • Middle East • Africa • Asia Contact Ernest Oncology—Pharmaceutical Exporter from India Group of Ernest Pharmaceutical Pvt. Ltd. 📞 Contact Ernest Oncology—Global Oncology Medicine Supplier [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp https://wa.me/919359902383 +91 93599 02383

GEFTINAT 250MG Tablet (Gefitinib) Global Supplier & Oncology Medicine Exporter – Ernest Impex GEFTINAT 250MG Tablet contains Gefitinib, a targeted anti-cancer medication used for the treatment of non-small cell lung cancer (NSCLC), particularly in patients with EGFR mutation-positive tumors. Ernest Impex is a trusted pharmaceutical exporter from India, supplying GEFTINAT 250MG Tablets globally to oncology hospitals, pharmaceutical distributors, cancer treatment centers, and international healthcare procurement agencies. Pharmaceutical buyers and healthcare providers in Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) rely on Ernest Impex for bulk supply of Gefitinib tablets with reliable global logistics, competitive export pricing, and high-quality pharmaceutical sourcing. What is GEFTINAT 250MG Tablet? GEFTINAT 250MG Tablet contains Gefitinib, an EGFR (Epidermal Growth Factor Receptor) Tyrosine Kinase Inhibitor, used in targeted cancer therapy. In many lung cancers, EGFR mutations cause cancer cells to grow and divide rapidly. Gefitinib blocks the EGFR signaling pathway responsible for cancer cell proliferation. By blocking these signals, the medicine helps: • Slow tumor growth • Prevent cancer cell multiplication • Reduce cancer spread • Improve treatment outcomes Due to this targeted mechanism, Gefitinib is widely used in modern precision oncology treatment protocols worldwide. Mechanism of Action The active ingredient Gefitinib selectively inhibits the EGFR tyrosine kinase enzyme. Its anti-cancer action includes: • Blocking EGFR receptor signaling • Preventing cancer cell growth and division • Inducing apoptosis (programmed cancer cell death) • Reducing tumor progression This targeted action makes GEFTINAT tablets effective in treating EGFR mutation-positive lung cancer patients. Medical Uses of GEFTINAT 250MG Tablet GEFTINAT tablets are commonly prescribed for: • Non-Small Cell Lung Cancer (NSCLC) • EGFR mutation-positive lung cancer • Advanced or metastatic lung cancer • Targeted therapy in oncology treatment programs Gefitinib is widely used in specialized oncology hospitals and cancer research centers worldwide. Product Information Product Name: GEFTINAT 250MG Tablet Generic Name: Gefitinib Strength: 250 mg Dosage Form: Oral Tablet Therapeutic Category: Anti-Cancer / EGFR Tyrosine Kinase Inhibitor Packaging: Blister pack / Export packaging Shelf Life: 24–36 months Storage: Store below 25°C in a cool and dry place Benefits of GEFTINAT Tablets • Advanced targeted therapy for lung cancer • Effective EGFR inhibitor used in oncology treatment • Helps slow cancer progression • Oral tablet for convenient treatment • Widely used in precision cancer therapy • Trusted targeted lung cancer medication worldwide Why Choose Ernest Impex? Ernest Impex is a leading global pharmaceutical exporter, supplying high-quality medicines to healthcare providers worldwide. Key advantages include: • GMP certified pharmaceutical sourcing • Competitive export pricing for bulk buyers • Reliable global pharmaceutical supply chain • OEM / Private Label pharmaceutical supply available • Fast international delivery via DHL, Aramex & Air Cargo • Trusted exporter of oncology medicines and specialty drugs Export Documentation Provided Ernest Impex provides complete export documentation including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents ensure smooth international pharmaceutical import and regulatory compliance. 📞 Contact Ernest Impex – Pharmaceutical Exporter from India 🌐 Websites www.ernestimpex.com www.ernestpharmaceuticals.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383

Geflieva 250mg Tablet: Precision EGFR Inhibition for Advanced Non-Small Cell Lung Cancer Are you searching for a reliable Geflieva 250mg Tablet exporter from India? Ernest Oncology, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of targeted tyrosine kinase inhibitors. We maintain an agile and secure supply chain for London (UK), Washington (USA), Canberra (Australia), and South Africa, ensuring that critical oncology medications reach institutional pharmacies with 100% pharmaceutical integrity. Detailed Product Profile: What is Geflieva 250mg? Geflieva 250mg is an oral targeted therapy containing the active pharmaceutical ingredient Gefitinib. Manufactured by Allieva Pharma Pvt Ltd, this 250mg tablet is a potent EGFR (Epidermal Growth Factor Receptor) tyrosine kinase inhibitor. It is specifically designed to treat patients with non-small cell lung cancer (NSCLC) that harbors specific activating mutations, offering a targeted alternative to traditional systemic chemotherapy. 1. Therapeutic Indications Metastatic Non-Small Cell Lung Cancer (NSCLC): Indicated as first-line treatment for patients whose tumors have specific EGFR mutations (such as exon 19 deletions or exon 21 L858R substitution mutations). Maintenance Therapy: Used in specific clinical settings to prevent disease progression in patients who have responded to initial platinum-based chemotherapy. Second-line Treatment: Utilized for patients whose cancer has progressed despite receiving prior chemotherapy protocols. 2. Mechanism of Action: Targeted Molecular Blockade EGFR Inhibition: It binds to the adenosine triphosphate (ATP) binding site of the enzyme tyrosine kinase associated with the Epidermal Growth Factor Receptor (EGFR). Signal Disruption: By blocking this site, Geflieva interrupts the signaling pathways (like Ras/Raf/MAPK) that are responsible for cancer cell survival, proliferation, and angiogenesis. Selective Cytotoxicity: Because it targets a specific receptor often overexpressed in lung cancer cells, it effectively inhibits tumor growth while sparing many types of healthy cells. 3. Administration and Dosage Management Standard Dosing: The typical recommended dose is one 250mg tablet taken once daily. Administration: Can be taken with or without food. Tablets should be swallowed whole; however, for patients with swallowing difficulties, the tablet can be dispersed in non-carbonated drinking water. Duration: Treatment is generally continued as long as the patient derives clinical benefit without experiencing unacceptable toxicity. Clinical Side Effects & Safety Monitoring Dermatological Safety: Skin rash (acneform) and dry skin are very common; monitoring for severe bullous or exfoliative conditions is required. Gastrointestinal Health: Potential for diarrhea, nausea, and vomiting. Persistent diarrhea may require clinical intervention or dose adjustment. Hepatotoxicity: Periodic Liver Function Tests (LFTs) are recommended as Gefitinib can cause elevations in liver enzymes. Pulmonary Monitoring: Rare but serious risk of Interstitial Lung Disease (ILD). Patients must report new or worsening shortness of breath or cough immediately. Ocular Health: Patients should be monitored for signs of keratitis or corneal erosion. Why Source Geflieva 250mg from Ernest Oncology? Verified Authenticity: Direct sourcing of Allieva Pharma’s Geflieva with full batch-specific COA and traceability. Logistics Authority: Expert handling of complex import/export regulations for USA, UK, Australia, and South Africa. Wholesale Solutions: Competitive bulk pricing for hospital groups, specialty pharmacies, and regional distributors. Regulatory Compliance: Every shipment includes GMP certificates and comprehensive B2B documentation to ensure global standards. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

Product Description Granisetron HCl Tablets 1 mg are prescription antiemetic medicines commonly prescribed to reduce nausea and vomiting caused by cancer chemotherapy and radiotherapy. The medicine belongs to the selective 5-HT3 receptor antagonist class, helping patients better tolerate cancer treatment by blocking serotonin signals involved in the vomiting reflex. other medicine ; Ondansetron Tablets 8 mg Aprepitant Capsules 125 mg Dexamethasone Tablets 4 mg Olanzapine Tablets 5 mg Metoclopramide Tablets 10 mg Gefitinib Tablets 250 mg Capecitabine Tablets 500 mg Erlotinib Tablets 150 mg What Other Information Should I Know? -Keep all scheduled follow-up appointments during therapy. -Never use expired tablets or medicines with damaged packaging. -Carry an updated list of all medicines you are taking, especially during hospital visits. -Dispose of unused tablets responsibly according to local pharmaceutical disposal guidelines. -This medicine is intended for individual prescription use and should never be shared with others. Serious Side Effects – Seek Medical Attention Immediately *Difficulty breathing or wheezing *Swelling of the lips, tongue, throat, or face *Severe skin rash, blistering, or peeling *Fast, slow, or irregular heartbeat *Sudden fainting or dizziness *Persistent abdominal swelling or severe constipation *Seizures or loss of consciousness *Symptoms of a severe allergic reaction Safety Advice: ✔ Use only with a valid prescription. ✔ Patients with liver or heart conditions should use this medicine under medical supervision. ✔ Pregnancy and breastfeeding should be discussed with a healthcare provider before treatment. ✔ Avoid driving or operating machinery if you experience dizziness after taking the medicine. Storage Instructions: -Protect from excessive heat, moisture, and direct sunlight. -Store in a dry location away from children and pets. -Do not use the medicine after its expiry date. -Return unused or expired medicines through approved disposal programs whenever possible. Export Documentation Available: regulatory documentation, including: -Certificate of Analysis (COA) -Certificate of Origin (COO) -Commercial Invoice -Packing List -Batch Details -Shipping Documents -Additional export documents as required by the destination country Frequently Asked Questions (FAQs) 1. What are Granisetron HCl Tablets 1 mg used for? They are prescription medicines used to help prevent nausea and vomiting associated with chemotherapy and radiotherapy. 2. Are these tablets available for wholesale export? Yes. Bulk quantities are available for licensed hospitals, pharmaceutical distributors, wholesalers, and authorized importers. 3. Can international buyers request regulatory documents? Yes. Eligible export orders can be supplied with commercial and quality documentation required for international distribution. 4. How should Granisetron Tablets be stored? Keep the tablets in their original packaging, stored in a cool, dry place away from heat, moisture, and direct sunlight. 5. Why do global buyers source Granisetron Tablets from India? Indian pharmaceutical suppliers are recognized for dependable manufacturing standards, competitive export pricing, reliable supply capacity, and extensive experience in serving international healthcare markets. #GranisetronTablets #Granisetron1mg #AntiemeticMedicine #CancerSupport #OncologyCare #HospitalPharmacy #MedicineSupplier #IndianPharma #BulkMedicine #PharmaceuticalExporter #HealthcareDistribution #GlobalPharma #CancerCareSupport #MedicalImports #WholesaleMedicines #HealthcareLogistics #HospitalProcurement #InternationalTrade #PharmaWholesale #ErnestPharmaceutica 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Procurement 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1 Granisetron HCl Tablets 1 mg, Buy Granisetron Tablets Online, Antiemetic Medicine Supplier, Oncology Support Medicine, Chemotherapy Nausea Tablets, Pharmaceutical Export India, Wholesale Cancer Support Medicine, Hospital Medicine Distributor, Global Pharma Supplier, Bulk Granisetron Tablets

Why Is This Medication Prescribed? Flutamide tablets 250 mg are prescribed to help manage certain hormone-sensitive prostate cancers. The medicine blocks androgen receptors, preventing testosterone from stimulating cancer cell growth. Depending on the patient's treatment plan, Flutamide may be used: Alongside LHRH (GnRH) agonist therapy. As part of combined androgen blockade. Before or after specific hormonal treatment protocols. According to individualized oncology or urology treatment plans. Treatment decisions are always based on clinical evaluation, disease stage, and specialist recommendations. How Should This Medicine Be Used? Flutamide should always be taken exactly as prescribed. General guidance includes: Swallow tablets whole with water. Take doses at evenly spaced intervals to maintain consistent medicine levels. Tablets may be taken with or without food unless instructed otherwise. Do not stop therapy without consulting your healthcare provider. Regular liver function tests and follow-up appointments may be advised during treatment. What Should I Do If I Forget a Dose? If you miss a scheduled dose: If the next dose is almost due, skip the forgotten tablet and continue with your regular schedule. If multiple doses are missed, contact your healthcare provider for further guidance. Why International Buyers Choose Flutamide 250mg ✔ High-quality pharmaceutical manufacturing ✔ Suitable for hospital and institutional procurement ✔ Bulk export quantities available ✔ International shipping support ✔ Export documentation available ✔ Reliable packaging for global distribution ✔ Consistent supply for licensed pharmaceutical buyers Global Oncology Market News Growing Demand for Hormonal Cancer Therapies Worldwide Healthcare providers across Europe, the Middle East, Asia, and Africa continue expanding access to hormone-based cancer therapies as prostate cancer screening and treatment programs increase. Pharmaceutical importers are seeking dependable suppliers capable of delivering quality-assured oncology medicines with complete export documentation, stable inventory, and efficient international logistics. Frequently Asked Questions 1. What is Flutamide Tablets 250mg mainly used for? It is prescribed as part of hormonal therapy for selected patients with hormone-sensitive prostate cancer under specialist supervision. 2. Can flutamide tablets be taken at home? Yes. It is an oral prescription medicine that should be taken exactly as directed by the treating physician. 3. Is Flutamide used alone? It is commonly used together with other hormonal therapies, depending on the patient's treatment plan. 4. Who can purchase Flutamide Tablets in bulk? Licensed importers, hospitals, oncology distributors, pharmacies, and government procurement agencies can source commercial quantities subject to local regulations. 5. What should buyers verify before placing an international order? Buyers should confirm shelf life, batch availability, packaging specifications, Certificate of Analysis (COA), Certificate of Origin (COO), and destination-country import requirements. *Buy Flutamide Tablets, 250 mg, Online *Flutamide Tablets Supplier UK *Flutamide Exporter India *Hormonal Cancer Medicine Supplier *Prostate Cancer Medicine Export *Bulk Flutamide Tablets *Oncology Tablet Distributor *Pharmaceutical Export Company India *Flutamide Wholesale Supplier *Antiandrogen Medicine Export #Flutamide250mg #FlutamideTablets #ProstateCancerTreatment #HormonalTherapy #OncologyMedicine #CancerMedicineSupplier #UKHealthcare #LondonPharma #BulkPharmaceuticals #IndianPharmaExporter #HospitalProcurement #GlobalPharmaTrade #LicensedMedicineSupplier #OncologyDistributor #HealthcareExports #MedicalWholesaler #CancerCareSolutions #InternationalMedicineSupply #PharmaExports #ErnestPharmaceutical 🌍 Ernest Oncology | Global Oncology Medicine Export Solutions [GROUP OF ERNEST PHARMACEUTICALS PVT. LTD.] 🌐 Websites: www.oncologymedicinesupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Export • Distribution • Procurement 📲 WhatsApp: +91 9405476170 https://wa.me/message/V2MEXZ6ZAYY5B1

About Products Abiraterone Acetate Tablets USP 250 mg are specialized prescription medicines used in the treatment of advanced prostate cancer. This medication works by blocking the CYP17 enzyme, which plays a key role in the production of androgens (male hormones). By reducing androgen levels, abiraterone helps slow the progression of prostate cancer. This therapy is typically administered alongside corticosteroids such as prednisone or prednisolone and should always be taken under the supervision of a qualified healthcare professional. Product Overview Table Product Detail Information Product Name Abiraterone Acetate Tablets USP Strength 250 mg Generic Name Abiraterone Acetate Dosage Form Oral Tablet Therapeutic Category Hormonal Anticancer Therapy Drug Class Androgen Production Inhibitor Route of Administration Oral Standard Pack Options Bottle or blister packs depending on manufacturer Prescription Status Prescription-only medication Supply Category Hospital, wholesale, distributor and export supply Target Locations Bangkok, Thailand and UAE UAE Capital Abu Dhabi Thailand Capital Bangkok Indications Abiraterone acetate is prescribed in combination with prednisone or prednisolone for adult male patients diagnosed with: Metastatic castration-resistant prostate cancer (mCRPC) Metastatic high-risk castration-sensitive prostate cancer (mCSPC) Advanced prostate cancer requiring ongoing hormone suppression therapy Patients are generally advised to continue androgen deprivation therapy using a GnRH analogue unless surgical castration has been performed. Dosing and Administration The standard recommended dosage of abiraterone acetate is: 1,000 mg once daily, which equals four 250 mg tablets, taken together as a single dose. For mCRPC, it is commonly prescribed with prednisone 5 mg twice daily. For mCSPC, prednisone 5 mg once daily may be recommended. The exact dosage and schedule should always be determined by the treating physician. Administration Guidelines Take the medication on an empty stomach. Avoid food for at least two hours before taking the dose. Do not eat for at least one hour after taking the tablets. Swallow tablets whole with water. Do not crush, chew, or break the tablets. Take the medication at the same time each day. Do not alter or stop prednisone without medical advice. FAQs 1. What is Abiraterone Acetate used for? It is used to treat advanced prostate cancer by reducing male hormone production. 2. How should Abiraterone be taken? It should be taken on an empty stomach, once daily, as prescribed by a doctor. 3. Can Abiraterone be taken with food? No, taking it with food can increase side effects due to higher absorption. 4. Is a prescription required for Abiraterone? Yes, it is a prescription-only medication and must be used under medical supervision. 5. Is Abiraterone supplied internationally? Yes, it is available for export to licensed buyers in Thailand, UAE, and other countries. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383 Buy Abiraterone Acetate Tablets USP 250mg online Abiraterone 250mg supplier Thailand Abiraterone tablets distributor Bangkok Abiraterone exporter, India Abiraterone 250mg supplier UAE Abiraterone tablets Dubai supplier Abiraterone wholesaler Abu Dhabi Oncology medicine supplier abiraterone Abiraterone bulk supplier Abiraterone 250mg wholesale cost Generic abiraterone exporter Prostate cancer drug supplier Hospital supply abiraterone tablets Abiraterone international exporter WHO-GMP certified oncology supplier Abiraterone tender supplier Abiraterone manufacturer India Abiraterone bottle supplier #Abiraterone #AbirateroneAcetate #Abiraterone250mg #ProstateCancerTreatment #OncologyDrugs #CancerCareMedicine #PharmaExporter #GlobalMedicineSupply #ThailandHealthcare #BangkokPharma #UAEMedicalSupply #AbuDhabiPharma #DubaiHealthcare #GenericPharmaceuticals #HospitalMedicines #ErnestImpex

Fulveser 250 mg Injection: Targeted Therapy for Advanced Breast Cancer Description: Learn about Fulveser 250 mg Injection (Fulvestrant), a targeted therapy for hormone receptor-positive advanced breast cancer. Explore its clinical uses, mechanism, and how Ernest Oncology facilitates global access. Fulvesar 250 mg Injection: Clinical Insights and Patient Safety Guidelines Product Profile: Understanding Fulvesar 250 mg Injection Fulvesar 250 mg Injection (Fulvestrant) is an essential medication in the oncology portfolio, specifically designed to treat hormone receptor-positive (HR+) advanced or metastatic breast cancer in postmenopausal women. As a Selective Estrogen Receptor Degrader (SERD), it provides a powerful therapeutic option, especially for patients whose cancer has progressed after initial hormonal therapy. 1. Clinical Indications & Usage HR+/HER2- Breast Cancer: Used as a monotherapy or in combination with other agents (such as CDK4/6 inhibitors) for advanced or metastatic disease in postmenopausal women. Post-Hormonal Therapy Progression: Prescribed for patients whose breast cancer has progressed during or after previous endocrine therapy (e.g., tamoxifen or aromatase inhibitors). Targeted Hormone Blockade: Serves as a definitive blockade of estrogen signaling, which is a primary driver of growth in hormone-sensitive breast tumors. 2. Mechanism of Action Estrogen Receptor Binding: Competitively binds to estrogen receptors (ER) with high affinity, effectively blocking estrogen from attaching to the receptor. Receptor Dimerization Impairment: Prevents the dimerization of estrogen receptors, which is a critical step for nuclear translocation and transcriptional activation. Downregulation of Receptors: Triggers the rapid degradation of existing estrogen receptor proteins, leading to a complete reduction of ER levels within the cell. 3. Administration and Dosing Guide Administration: Administered as an intramuscular (IM) injection slowly into the buttocks. It is typically given as two separate injections (one in each buttock) to accommodate the required dose. Schedule: The standard loading regimen is usually administered on days 1, 15, and 29, followed by once-monthly maintenance injections. Supervision: Must be administered only by a qualified healthcare professional in a clinical setting. Consistency: Adherence to the scheduled injection cycle is vital to maintain consistent plasma levels and therapeutic efficacy. ⚠️ Safety, Side Effects, and Monitoring Injection Site Reactions: Common side effects include pain, inflammation, or bruising at the site of the injection. Hormonal Impacts: Frequently causes hot flashes, fatigue, and headache. Hematologic Risks: May affect blood counts; regular monitoring of platelet levels is recommended, especially in patients with bleeding disorders. Monitoring: Patients should undergo periodic liver function tests and monitoring for potential thromboembolic events. 📦 Storage and Handling Specifications Temperature: Store strictly at refrigerated temperatures (2°C to 8°C). Protection: Protect from light and do not freeze. Handling: Inspect the pre-filled syringe for any particulate matter or discoloration prior to administration. Security: Ensure the medication is kept in a secure, climate-controlled environment, inaccessible to unauthorized individuals. 📄 Regulatory and Compliance Documentation Global Quality Standards: Sourced from manufacturing facilities compliant with WHO-GMP and international pharmaceutical standards. Batch Verification: Each shipment includes a Certificate of Analysis (COA) to confirm purity, potency, and safety profile. Export Documentation: We provide comprehensive regulatory dossiers to facilitate smooth import and customs clearance in the USA, UK, Australia, and South Africa. Pharmacovigilance: We maintain rigorous reporting protocols to monitor product safety and ensure adherence to international distribution requirements. WHY CHOOSE ERNEST ONCOLOGY? Global Reach: Uncompromising Quality Logistical Precision PRESCRIPTION MEDICINE: YES Disclaimer: This information is for educational purposes only and does not constitute medical advice. Fulvestrant is a high-potency prescription medication that must be administered only under the strict supervision of a qualified oncologist. It is contraindicated for use during pregnancy or breastfeeding. Always consult with your healthcare provider for diagnosis and treatment plans. 📞 Contact Ernest Oncology—Pharmaceutical Medicine Exporter (GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.) Websites: www.oncologymedicinesupplier.com | www.ernestpharmaceuticals.com | www.ernestimpex.com | www.ernestvision.com Email: exports@ernestpharmaceuticals.com Business Type: Exporter | Bulk Supplier | Distributor WhatsApp: +91 93599 02383 WhatsApp Link: https://wa.me/919359902383

The Comprehensive Guide to Temalieva 250 mg Capsules In precision neuro-oncology and general cancer care, Temalieva 250 mg capsules (containing the active ingredient Temozolomide) stand as a critical therapeutic agent for treating aggressive brain tumors. As a premier pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this life-saving medication is accessible to hospitals, pharmacies, and healthcare systems in London, the UK, the USA, Australia, and South Africa with full regulatory compliance. Product SpecificationsFeatureDetailBrand NameTemalieva 250 (Temozolomide Capsules IP)Strength250 mgDosage FormOral Hard Gelatin CapsulePrimary IndicationGlioblastoma multiforme & anaplastic astrocytomaStorageStore below 25°C in a cool, dry place. Protect from moisture and light. Mechanism of Action: How It Works DNA Alkylation: Once ingested, Temozolomide readily crosses the blood-brain barrier. At physiological pH, it is converted into the active compound MTIC. Interfering with Replication: MTIC methylates DNA at specific locations, which causes DNA strand breaks and cross-linking. This process inhibits the multiplication and growth of rapidly dividing cancer cells, ultimately leading to programmed cell death (apoptosis). Therapeutic Indications & Administration Glioblastoma Multiforme (GBM): Used for newly diagnosed GBM patients in combination with focal radiation therapy, followed by maintenance therapy. Refractory Anaplastic Astrocytoma: Treatment for patients experiencing tumor recurrence or progression after standard therapy. Administration Guidelines Dosing Schedule: Dosing is calculated based on the patient's body surface area (BSA). Ingestion: Swallow the capsules whole with a full glass of water. Do not open, crush, or chew the capsule contents to prevent exposure to the active drug. Minimizing Side Effects: To reduce the incidence of nausea and vomiting, patients are often advised to take the medication on an empty stomach or at bedtime. Clinical Side Effects & Safety Profile Common Side Effects: Nausea, vomiting, headache, fatigue, constipation, and loss of appetite. Prophylactic antiemetics are frequently prescribed. Myelosuppression: The most serious clinical risk is a decrease in bone marrow function, which leads to reduced white blood cell and platelet counts. This increases susceptibility to infections and bruising or bleeding. Liver Function: Patients should undergo regular liver function tests (LFTs) due to the potential for hepatotoxicity. Contraindications: It is contraindicated during pregnancy and breastfeeding due to the risk of fetal harm. Male patients must use effective contraception during treatment and for at least 3 months afterward. Why Source from Ernest Oncology? United Kingdom (London): Providing high-quality, cost-effective generic alternatives for private and public healthcare systems. USA: Delivering bulk quantities that comply with international documentation and safety standards. Australia: Facilitating secure access through compliant supply channels such as the “Special Access Scheme“ (SAS). South Africa: Bridging critical gaps in the oncology market with affordable, high-tier pharmaceutical exports from India. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383